Patient Blood Management: Single Center Evidence and Practice at Fuwai Hospital

Chinese Medical Sciences Journal

Volumn 37, Issue 3, 2022, Pages 246-261

  Yao, Yuntai ^a   Yuan, Xin ^a   He, Lixian ^a   Yu, Yiping ^a   Du, Yu ^a   Liu, Gang ^a   Tian, Lijuan ^a   Ma, Zuxuan ^a   Zhang, Yongbao ^a   Ma, Jie ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

anesthesia; bleeding; blood management; blood transfusion; cardiovascular surgery

Indexed keywords

APROTININ; BATROXOBIN; DESMOPRESSIN; FIBRINOGEN CONCENTRATE; HEMOSTATIC AGENT; PROTHROMBIN COMPLEX; TRANEXAMIC ACID; ULINASTATIN; VITAMIN K GROUP;

ANEMIA; ANTICOAGULATION; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD CELL; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CARDIOPULMONARY BYPASS; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DUAL ANTIPLATELET THERAPY; EVIDENCE BASED PRACTICE; HEALTH CARE FACILITY; HEALTH CARE PLANNING; HEART MUSCLE REVASCULARIZATION; HEMODILUTION; HUMAN; INTERDISCIPLINARY RESEARCH; PATIENT CARE; PATIENT MONITORING; PERIOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; SURGICAL TECHNIQUE; THROMBOCYTOPHERESIS; ULTRAFILTRATION; VACUUM ASSISTED CLOSURE; BLEEDING; HOSPITAL; OPERATIVE BLOOD LOSS; PROCEDURES;

ANEMIA; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HEMORRHAGE; HOSPITALS; HUMANS;

EID: 85138285901     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.24920/004035     Document Type: Article

References (100)

1. Görlinger, K, Shore-Lesserson, L, Dirkmann, D, et al. Management of hemorrhage in cardio-thoracic surgery. J Cardiothorac Vasc Anesth 27:Suppl 4 (2013), S20–S34 doi:10.1053/j.jvca.2013.05.014.
2. Shander, AS, Goodnough, LT, Blood transfusion as a quality indicator in cardiac surgery. JAMA 304:14 (2010), 1610–1611 doi:10.1001/jama.2010.1483.
3. Yu, X, Huang, Y, Qu, G, et al. Safety and current status of blood transfusion in China. Lancet 375:9724 (2010), 1420–1421 doi:10.1016/S0140-6736(10)60003-7.
4. Yu, X, Chen, W, Liu, Z, et al. Safety and current status of blood transfusion in China: an update. Lancet Hematol 3:2 (2016), e60–e62 doi:10.1016/S2352-3026(16)00010-7.
5. Lu, J, Cheng, W, Huang, J, Report on cardiac anesthesia progress and challenges in China. J Cardiothorac Vasc Anesth 32:5 (2018), 2365–2371 doi:10.1053/j.jvca.2017.12.050.
6. Lu, J, Wang, W, Cheng, W, et al. Current status of cardiovascular anesthesia in China. Anesth Analg 125:6 (2017), 1855–1862 doi:10.1213/ANE.0000000000002051.
7. Shan, H, Zhang, P, Viral attacks on the blood supply: the impact of severe acute respiratory syndrome in Beijing. Transfusion 44:4 (2004), 467–469 doi:10.1111/J.0041-1132.2004.04401.x.
8. Duru, F, Fuwai Hospital, Beijing, China: the world's largest cardiovascular science centre with more than 1200 beds. Eur Heart J 39:6 (2018), 428–429 doi:10.1093/eurheartj/ehx804.
9. Li, LH, The effects of cardiopulmonary bypass on coagulation and thrombosis. Int J Anesth Resus 1 (1981), 9–15.
10. Hu, RL, Sun, YP, Liu, J, et al. The application of activated clotting time response curve on calculating protamine dosages. Chin Circ J 2 (1988), 119–121 doi:10.3321/j.issn:1000-3614.1988.02.036.
11. Hu, RL, Liu, J, Xu, SC, Optimal dose of domestic and imported protamine on heparin. Chin Circ J 4 (1989), 366–367 doi:10.3321/j.issn:1000-3614.1989.04.031.
12. Liu, J, Hu, RL, Xu, SC, The protamine reversal after residue pump blood transfusion. Chin Circ J 2 (1990), 159–160 doi:10.3321/j.issn:1000-3614.1990.02.034.
13. Long, C, Hu, XQ, Deng, SZ, Heparinization during cardiopulmonary bypass. Int J Anesth Resus 1 (1992), 3–6.
14. Long, C, Hu, XQ, Anticoagulation for contact activation-heparin coated circuit. Int J Bio Eng 4 (1993), 201–205.
15. Hu, XQ, Wu, XR, Long, C, et al. Autotransfusion during open heart surgery. Acta Acad Med Sin, 4, 1994, 284 doi:10.3321/j.issn:1000-503X.1994.04.012.
16. Deng, SZ, Liu, J, Blood transfusion and related adverse events. J Clin Anesth, 1, 1995, 31.
17. Wu, QY, Reduction of blood transfusion in cardiovascular surgery. Chin Circ J, 15, 2000, 372 doi:10.3321/j.issn:1000-3614.2000.06.032.
18. Ji, H, Li, Z, Sun, H, et al. Effects of multidisciplinary blood management strategy on transfusion and outcomes in patients undergoing valvular heart surgery. Zhonghua Yi Xue Za Zhi 94:7 (2014), 488–490 Chinese. doi:10.3760/cma.j.issn.0376-2491.2014.07.004.
19. Fuwai Hospital, CAMS National Center for Cardiovascular diseases. Cardiovascular surgery outcomes 2019. Available from: https://www.fuwai.com/Sites/Uploaded/File/2020/8/2019waike.pdf. (Accessed 1 April 2021)
20. Hansson, EC, Jeppsson, A, Platelet inhibition and bleeding complications in cardiac surgery: a review. Scand Cardiovasc J 50:5-6 (2016), 349–354 doi:10.1080/14017431.2016.1231935.
21. Levy, JH, Rossaint, R, Zacharowski, K, et al. What is the evidence for platelet transfusion in perioperative settings?. Vox Sang 112:8 (2017), 704–712 doi:10.1111/vox.12576.
22. Thiele, T, Greinacher, A, Platelet transfusion in perioperative medicine. Semin Thromb Hemost 46:1 (2020), 50–61 doi:10.1055/S-0039-1697951.
23. Pan, N, Gao, XR, Jia, JN, et al. Analysis of the characteristics of platelet transfusion in cardiovascular surgery. Beijing Med 38 (2016), 1221–1224 doi:10.15932/j.0253-9713.2016.11.026.
24. Wu, H, Hu, SS, Zheng, Z, et al. Predictors of perioperative blood transfusion after coronary artery bypass grafting. Chin J Blood Transfusion 25 (2012), 336–340 doi: 10.13303/j.cjbt.issn.1004549x.2012.04.035.
25. Chen, L, Lv, L, Long, C, et al. Evaluation of risk factors on red blood cells transfusion for patients underwent coronary artery bypass grafting perioperatively. Chin J Clin Thorac Cardiovasc Surg 23 (2016), 653–657.
26. Zhang, W, Chen, S, Liu, X, et al. Can higher body mass index patients save blood following on-pump coronary artery bypass grafting?. Heart Surg Forum 22:5 (2019), E352–E356 doi:10.1532/hsf.2559.
27. Wang, M, Chen, M, Ao, H, et al. The effects of different BMI on blood loss and transfusions in Chinese patients undergoing coronary artery bypass grafting. Ann Thorac Cardiovasc Surg 23:2 (2017), 83–90 doi:10.5761/atcs.oa.16-00219.
28. Liu, X, Zhang, W, Chen, N, et al. Can preoperative C-reactive protein predict bleeding after on-pump coronary artery bypass grafting?. Ann Thorac Surg 109:2 (2020), 541–546 doi:10.1016/j.athoracsur.
29. Shen, RH, Wang, X, Lu, ZY, et al. Development of nomogram predicting postoperative blood loss among pediatric patients following corrective operation of tetralogy of Fallot. Chin J Clin Thorac Cardiovasc Surg 28:4 (2020), 409–415 doi:10.7507/1007-4848.202003089.
30. Horvath, KA, Acker, MA, Chang, H, et al. Blood transfusion and infection after cardiac surgery. Ann Thorac Surg 95:6 (2013), 2194–2201 doi:10.1016/j.athoracsur.2012.11.078.
31. Reeves, BC, Murphy, GJ, Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery. Curr Opinion Cardiol 23:6 (2008), 607–612 doi:10.1097/ACO.0b013e32830dd087.
32. Ranucci, M, Outcome measures and quality markers for perioperative blood loss and transfusion in cardiac surgery. Can J Anesth 63:2 (2016), 169–175 doi:10.1007/s12630-015-0515-8.
33. Wu, H, Hu, SS, Zheng, Z, et al. Influence of perioperative blood transfusion on short-term, long-term outcomes after coronary artery bypass grafting. Chin Gen Pract 16:30 (2013), 3554–3558 doi:10.3969/j.issn.1007-9572.2013.28.083.
34. Wang, XQ, Sun, ZQ, Gao, HW, et al. Impact of blood transfusion on the prognosis for patients with coronary artery bypass grafting. Chin J Blood Transfusion 30:12 (2017), 1353–1356 doi:10.13303/j.cjbt.issn.1004-549x.2017.12.011.
35. Yao, YT, Li, LH, Lei, Q, et al. Noninfectious fever following aortic surgery: incidence, risk factors, and outcomes. Chin Med Sci J 24:4 (2009), 213–219 doi:10.1016/s1001-9294(10)60004-1.
36. Xu, DQ, Wu, H, Zhang, HT, et al. Risk factors of postoperative hyperbilirubinemia in cardiac surgical patients. Chin J Med 49 (2014), 19–21 doi:10.3969/j.issn.1008-1070.2014.06.006.
37. Padmanabhan, H, Siau, K, Curtis, J, et al. Preoperative anemia and outcomes in cardiovascular surgery: systematic review and meta-analysis. Ann Thorac Surg 108:6 (2019), 1840–1848 doi:10.1016/j.athoracsur.2019.04.108.
38. Dhir, A, Tempe, DK, Anemia and patient blood management in cardiac surgery—literature review and current evidence. J Cardiothorac Vasc Anesth 32:6 (2018), 2726–2742 doi:10.1053/j.jvca.2017.11.043.
39. Xu, H, Duan, Y, Yuan, X, et al. Intravenous iron versus placebo in the management of postoperative functional iron deficiency anemia in patients undergoing cardiac valvular surgery: a prospective, single-blinded, randomized controlled trial. J Cardiothorac Vasc Anesth 33:11 (2019), 2941–2948 doi:10.1053/j.jvca.2019.01.063.
40. Wang, S, Lv, S, Guan, Y, et al. Cardiopulmonary bypass techniques and clinical outcomes in Beijing Fuwai Hospital: a brief clinical review. ASAIO J 57:5 (2011), 414–420 doi:10.1097/MAT.0b013e318227fa72.
41. Xiong, Y, Sun, Y, Ji, B, et al. Systematic review and meta-snalysis of benefits and risks between normothermia and hypothermia during cardiopulmonary bypass in pediatric cardiac surgery. Paediatr Anesth 25:2 (2015), 135–142 doi:10.1111/pan.12560.
42. Chen, L, Lv, L, Long, C, et al. Effects of circuit albumin coating on coagulation and inflammatory response for patients receiving aortic arch replacement: a randomized controlled trial. Perfusion 31:7 (2016), 576–583 doi:10.1177/0267659116645662.
43. Gao, S, Li, Y, Diao, X, et al. Vacuum-assisted venous drainage in adult cardiac surgery: a propensity-matched study. Interact Cardiovasc Thorac Surg 30:2 (2020), 236–242 doi:10.1093/icvts/ivz253.
44. Liu, G, Zeng, QD, Zheng, Z, et al. Clinical application of modified minimally cardiopulmonary bypass: compared with conventional cardiopulmonary bypass. Zhonghua Wai Ke Za Zhi 54:8 (2016), 613–616 doi:10.3760/cma.j.issn.0529-5815.2016.08.012.
45. Yan, S, Zhao, Y, Lou, S, Ultrafiltration and reinfusion of residual cardiopulmonary bypass pump blood: a prospective non-randomized controlled study. Artif Organs 43:7 (2019), 641–646 doi:10.1111/aor.13412.
46. Ferraris, VA, Brown, JR, Despotis, GT, et al. Society of Thoracic Surgeons Blood Conservation Guideline Task Force. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 91:3 (2011), 944–982 doi:10.1016/j.athoracsur.2010.11.078.
47. Tian, L, Gao, X, Yang, J, et al. Association of adenosine diphosphate-induced platelet maximum amplitude with postoperative bleeding and blood transfusions in patients undergoing coronary artery bypass grafting. J Cardiothorac Vasc Anesth 35:2 (2021), 421–428 doi:10.1053/j.jvca.2020.07.009.
48. Ji, HW, Deng, SZ, Changes of plasma heparin concentration during cardiopulmonary bypass. J Clin Anesth 19:3 (2003), 139–141 doi:10.3969/j.issn.1004-5805.2003.03.003.
49. Boer, C, Meesters, MI, Veerhoek, D, et al. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review. Br J Anaesth 120:5 (2018), 914–927 doi:10.1016/j.bja.2018.01.023.
50. Wang, G, Xie, G, Jiang, T, et al. Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. Anesth Analg 115:2 (2012), 239–243 doi:10.1213/ANE.0b013e3182264a11.
51. Wang, JH, Han, ZY, Lin, L, et al. Anesthetic management for 1-stop hybrid revascularization of coronary artery disease. Natl Med J China 90:17 (2010), 1181–1183 doi:10.3760/cma.j.issn.0376-2491.2010.17.008.
52. Zhu, GY, Shi, SH, Zhang, BZ, et al. Hemodilution and autotransfusion during cardiovascular surgery: a serial report of 100 cases. Chin J Blood Transfusion 3:3 (1990), 122–124 doi:10.13303/j.cjbt.issn.1004-549x.1990.03.010.
53. Schaff, HV, Hauer, J, Gardner, TJ, et al. Routine use of autotransfusion following cardiac surgery: experience in 700 patients. Ann Thorac Surg 27:6 (1979), 493–499 doi:10.1016/50003-4975(10)63357-7.
54. Zhao, K, Xu, J, Hu, S, et al. Autotransfusion of shed mediastinal blood after open heart surgery. Chin Med J (Engl) 116:8 (2003), 1179–1182.
55. Wang, G, Bainbridge, D, Martin, J, et al. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 109:2 (2009), 320–330 doi:10.1213/ane.0b013e3181aa084c.
56. Woodman, RC, Harker, LA, Bleeding complications associated with cardiopulmonary bypass. Blood 76:9 (1990), 1680–1697.
57. Shi, S, Wang, GY, Preoperative autologous plateletpheresis in cardiac surgery—70 cases experiences at Fuwai Hospital. Mol Cardio Chin 18:6 (2018), 2678–2681 doi:10.16563/j.cnki.1671-6272.2018.12.009.
58. Takagi, H, Manabe, H, Kawai, N, et al. Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials. Interact Cardiovasc Thorac Surg 9:1 (2009), 98–101 doi:10.1510/icvts.2008.198325.
59. Liu, MZ, Zhang, DY, Hu, XQ, The application of aprotinin in open heart surgery. Chin Circ J 9:10 (1994), 611–613 doi:10.3321/j.issn:1000-3614.1994.10.025.
60. Fergusson, DA, Hébert, PC, Mazer, CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358:22 (2008), 2319–2331 doi:10.1056/NEJMoa0802395.
61. Wang, X, Zheng, Z, Ao, H, et al. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China. J Thorac Cardiovasc Surg 138:4 (2009), 897–903 doi:10.1016/j.jtcvs.2009.03.021.
62. Wang, X, Zheng, Z, Ao, H, et al. Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. Ann Thorac Surg 89:5 (2010), 1489–1495 doi:10.1016/j.athoracsur.2010.02.006.
63. Ji, BY, Liu, JP, Liu, MZ, et al. Effects of urinary protease inhibitor on inflammatory response during on-pump coronary revascularisation. Effect of ulinastatin on inflammatory response. J Cardiovasc Surg (Torino) 48:4 (2007), 497–503.
64. Yao, YT, Fang, NX, Liu, DH, et al. Ulinastatin reduces postoperative bleeding and red blood cell transfusion in patients undergoing cardiac surgery: a PRISMA-compliant systematic review and meta-analysis. Medicine, 99(7), 2020, e19184 doi:10.1097/MD.0000000000019184.
65. Zhang, P, Lv, H, Qi, X, et al. Effect of ulinastatin on post-operative blood loss and allogeneic transfusion in patients receiving cardiac surgery with cardiopulmonary bypass: a prospective randomized controlled study with 10-year follow-up. J Cardiothorac Surg, 15(1), 2020, 98 doi:10.1186/s13019-020-01144-9.
66. Wang, HL, Li, L, Zhou, Y, et al. Effects of ulinastatin in infants undergoing repair surgery for ventricular septal defect. Mol Cardiovasc Chin 19:5 (2019), 3061–3063 doi:10.16563/j.enki.1671-6272.2019.10.007.
67. Lv, H, Li, L, Lv, HR, et al. The pulmonary protective effect of ulinastatin in pediatric patients undergoing radical surgery for tetralogy of Fallot and its 7-year follow-up results. Chin J ECC 17:3 (2019), 153–156 doi:10.13498/j.cnki.chin.j.ecc.2019.03.07.
68. Yao, YT, He, LX, Tan, JC, The effect of tranexamic acid on the values of activated clotting time in patients undergoing cardiac surgery: a PRISMA-compliant systematic review and meta-analysis. J Clin Anesth, 67, 2020, 110020 doi:10.1016/j.jclinane.2020.110020.
69. Zhang, Y, Gao, X, Yuan, S, et al. Effects of tranexamic acid on short-term and long-term outcomes of on-pump coronary artery bypass grafting: randomized trial and 7-year follow-up. Cardiovasc Ther, 36(6), 2018, e12472 doi:10.1111/1755-5922.12472.
70. Shi, J, Wang, G, Lv, H, et al. Tranexamic acid in on-pump coronary artery bypass grafting without Clopidogrel and aspirin cessation: randomized trial and 1-year follow-up. Ann Thorac Surg 95:3 (2013), 795–802 doi:10.1016/j.athoracsur.2012.07.015.
71. Shi, J, Ji, H, Ren, F, et al. Protective effects of tranexamic acid on Clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. JAMA Surg 148:6 (2013), 538–547 doi:10.1001/jamasurg.2013.1560.
72. Zhang, Y, Zhang, X, Wang, Y, et al. Efficacy and safety of tranexamic acid in pediatric patients undergoing cardiac surgery: a single-center experience. Front Pediatr, 7, 2019, 181 doi:10.3389/fped.2019.00181.
73. Du, Y, Xu, J, Wang, G, et al. Comparison of two tranexamic acid dose regimens in patients undergoing cardiac valve surgery. J Cardiothorac Vasc Anesth 28:5 (2014), 1233–1237 doi:10.1053/ijvea.2013.10.006.
74. Lin, DM, Murphy, LS, Tran, MH, Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review. Transfus Med Rev 27:2 (2013), 91–104 doi:10.1016/j.tmrv.2013.01.002.
75. Cui, YL, Liu, JP, Feng, ZY, et al. Effect of fibrinogen on perioperative coagulation and short time prognosis for severe cyanotic congenital heart disease patients undergoing complex cardiac surgery. J Appl Clin Pediatr 27:19 (2012), 1533–1535 doi:10.3969/j.issn.1003-515X.2012.19.026.
76. Li, JY, Gong, J, Zhu, F, et al. Fibrinogen concentrate in cardiovascular surgery: a meta-analysis of randomized controlled trials. Anesth Analg 127:3 (2018), 612–621 doi:10.1213/ANE.0000000000003508.
77. Ghadimi, K, Levy, JH, Welsby, IJ, Prothrombin complex concentrates for bleeding in the perioperative setting. Anesth Analg 122:5 (2016), 1287–1300 doi:10.1213/ANE.0000000000001188.
78. Ponschab, M, Landoni, G, Biondi-Zoccai, G, et al. Recombinant activated factor VII increases stroke in cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 25:5 (2011), 804–810 doi:10.1053/j.jvca.2011.03.004.
79. Zangrillo, A, Mizzi, A, Biondi-Zoccai, G, et al. Recombinant activated factor VH in cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 23:1 (2009), 34–40 doi:10.1053/ijvca.2008.09.017.
80. Li, Y, Zhao, W, Luo, Q, et al. A propensity-score matched analysis on outcomes using recombinant activated factor VH in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 33:5 (2019), 1269–1275 doi:10.1053/j.jvca.2018.12.016.
81. Cattaneo, M, The use of desmopressin in open-heart surgery. Hemophilia 14:Suppl l (2008), 40–47 doi:10.1111/j.1365-2516.2007.01608.X.
82. Jin, L, Ji, HW, Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chin Med J (Engl) 128:5 (2015), 644–647 doi:10.4103/0366-6999.151663.
83. Zhao, WB, Li, J, Application of desmopressin during cardiopulmonary bypass in heart surgery. Hainan Med J 24:12 (2013), 1737–1739.
84. Sankar, MJ, Chandrasekaran, A, Kumar, P, et al. Vitamin K prophylaxis for prevention of vitamin K deficiency bleeding: a systematic review. J Perinatol 36:Suppl 1 (2016), S29–S35 doi:10.1038/jp.2016.30.
85. Yiu, KH, Siu, CW, Jim, MH, et al. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves. Am J Cardiol 97:3 (2006), 409–411 doi:10.1016/j.amjcard.2005.08.062.
86. Lv, XD, Long, C, Yao, YL, et al. Effect of vitamin K1 on perioperative blood coagulation factors during open heart surgery in Children. Chin J Clin Thorac Cardiovasc Surg 8:1 (2001), 8–11.
87. Lv, XD, Long, C, Yao, YL, et al. The effects of preoperative intramuscular injection of vitamin K on coagulation in patients undergoing open heart surgery. Shandong Med J 40:23 (2000), 19–21.
88. Yao, YT, Yuan, X, Fang, NX, Hemocoagulase reduces postoperative bleeding and blood transfusion in cardiac surgical patients: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore), 98(52), 2019, e18534 doi:10.1097/MD.0000000000018534.
89. Pereira, BM, Bortoto, JB, Fraga, GP, Topical hemostatic agents in surgery: review and prospects. Rev Col Bras Cir, 45(5), 2018, e1900 doi:10.1590/0100-6991e-20181900.
90. Raphael, J, Mazer, CD, Subramani, S, et al. Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients. Anesth Analg 129:5 (2019), 1209–1221 doi:10.1213/ANE.0000000000004355.
91. Mueller, MM, Van Remoortel, H, Meybohm, P, et al. Patient Blood Management: recommendations from the 2018 Frankfurt Consensus Conference. JAMA 321:10 (2019), 983–997 doi:10.1001/jama.2019.0554.
92. Boer, C, Meesters, MI, Milojevic, M, et al. Task Force on Patient Blood Management for Adult Cardiac Surgery of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Cardio-thoracic Anaesthesiology (EACTA). 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth 32:1 (2018), 88–120 doi:10.1053/j.jvca.2017.06.026.
93. Society of Thoracic Surgeons Blood Conservation Guideline Task Force Ferraris, VA, Ferraris, SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 83:5 Suppl (2007), S27–S86 doi:10.1016/j.athoracsur.2007.02.099.
94. Carson, JL, Stanworth, SJ, Roubinian, N, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev, 10(10), 2016, CD002042 doi:10.1002/14651858.CD002042.pub4.
95. Cholette, JM, Willems, A, Valentine, SL, et al. Recommendations on RBC transfusion in infants and children with acquired and congenital heart disease from the pediatric critical care transfusion and anemia expertise initiative. Pediatr Crit Care Med 19:9S Suppl 1 (2018), S137–S148 doi:10.1097/PCC.0000000000001603.
96. Dunning, J, Versteegh, M, Fabbri, A, et al. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 34:1 (2008), 73–92 doi:10.1016/j.ejcts.2008.02.024.
97. Erdoes, G, Martinez Lopez De Arroyabe, B, Bolliger, D, et al. International consensus statement on the peri-operative management of direct oral anticoagulants in cardiac surgery. Anaesthesia 73:12 (2018), 1535–1545 doi:10.1111/anae.14425.
98. Hu, SS, Ji, HW, Sun, HS, et al. Chinese expert consensus statement on patient blood management in patients undergoing cardiovascular surgery. Chin J Blood Transfusion 31:4 (2018), 321–325 doi: 10.13303/j.cjbt.issn.1004-549x.2018.04.001.
99. Chinese Society of Cardiothoracic and Vascular Anesthesiology, Perioperative Blood Management in Cardiovascular Surgery—Guidelines for Antifibrinolytic Therapy. J Clin Anesth 32:11 (2016), 1137–1140.
100. Chinese Society of Anesthesiology, Guidelines for perioperative fluid and blood transfusion management in pediatric patients. Practical J Organ Transplant 3:6 (2015), 328–332 doi:10.3969/j.issn.2095-5332.2015.06.002.